Honz Pharmaceutical Co., Ltd. (SZSE:300086) announced a private placement of not more than 135,000,000 A shares for gross proceeds of CNY 634,611,400 on November 9, 2020. The maximum number of issued shares does not exceed 30% of total share capital before the issuance. The pricing base date of this transaction is the first day of the issue period, and the issue price is not less than 80% of the average price of the company's stocks 20 trading days before the first day of the issue period. The transaction included participation from not more than 35 special investors. The share will issue at par value of CNY 1. The transaction has been approved by 10th meeting of the 5th directorate of the company and are subject to the approval of the company's shareholders meeting, Shenzhen Stock Exchange and the China Securities Regulatory Commission. The shares issued are subject to a hold period of 6 months from the date of issuance. The transaction is valid for 12 months from the date of deliberation and approval by the company's shareholders meeting.